Do diabetes autoantibodies predict progression to diabetes in adults : the Diabetes Prevention Program?
These data suggest that 'diabetes autoimmunity', as reflected by GAD antibodies and insulinoma-associated-2 autoantibodies, in middle-aged individuals at risk for diabetes is not a clinically relevant risk factor for progression to diabetes.
This is the first Canadian case-register study to support the widely reported falling rates of schizophrenia in other parts of the world over the last 40 years. Since this is a geographically limited prevalence study based on only 10 years of data, further research over longer periods of time in other regions of the country is required to support or refute these findings.